Open-Angle Glaucoma (OAG) Market Insights Report: Opportunities and Drivers 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the open-angle glaucoma (oag) market from 2026–2035 with trusted insights from The Business Research Company
What is the estimated market size of the Open-Angle Glaucoma (OAG) Market by the end of 2030?
The open-angle glaucoma (oag) market has demonstrated strong growth in recent years. This market is anticipated to expand from $6.53 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. In the past, this growth was primarily fueled by limited access to in-person mental health services, an increasing prevalence of anxiety and depression, greater awareness regarding the importance of mental health, the rising adoption of early telemedicine platforms, and the early implementation of online counseling programs.
The open-angle glaucoma (oag) market is projected to experience substantial growth in the coming years, with its size expected to reach $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This anticipated growth during the forecast period can be attributed to factors such as an increasing demand for accessible online therapy, the rising adoption of mobile and web-based counseling tools, the growing integration of AI-powered mental wellness solutions, an increasing utilization of hybrid therapy models that combine individual and group sessions, and the expansion of online therapy offerings in both commercial and residential sectors. Furthermore, key trends anticipated for the forecast period include a rising adoption of prostaglandin analog drugs, an increasing use of minimally invasive glaucoma surgeries, enhanced awareness regarding early diagnosis and screening, an uptick in teleophthalmology consultations for oag management, and the continued development of combination drug therapies.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp
What Drivers Are Shaping Future Opportunities In The Open-Angle Glaucoma (OAG) Market?
The open-angle glaucoma (OAG) market is expected to expand going forward due to increasing public understanding of eye illnesses. These conditions encompass medical issues impacting the eye’s structure, function, or vision, ranging from minor problems like dry eye to severe ailments such as glaucoma and macular degeneration. Their prevalence is rising, influenced by an aging global population, increased screen time, a growing number of diabetes cases, environmental pollution, and lifestyle choices that negatively affect eye health. Open-angle glaucoma (OAG) stands as a leading cause of blindness, particularly among older adults, emphasizing the critical importance of regular eye exams, early detection, and proactive treatment to prevent irreversible vision loss. For instance, in October 2023, information from the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, indicated that eye care outpatient appointments in the UK surpassed eight million in 2021/22, making it the most demanded specialty. Moreover, the number of individuals experiencing sight loss, currently exceeding two million, is anticipated to double to over four million by 2050. Thus, the escalating awareness concerning eye illnesses is fueling growth in the open-angle glaucoma (OAG) market.
Which Segments Are Gaining Traction In The Open-Angle Glaucoma (OAG) Market?
The open-angle glaucoma (oag) market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma
Which Trends Are Guiding The Evolution Of The Open-Angle Glaucoma (OAG) Market?
Major companies active in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less invasive alternatives for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a range of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, introduced MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.
Who Are The Prominent Global Companies Shaping The Open-Angle Glaucoma (OAG) Market Landscape?
Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report
Which Region Is Projected To Lead The Open-Angle Glaucoma (OAG) Market During The Forecast Period?
North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Open-Angle Glaucoma (OAG) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp
Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company
Ocular Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/ocular-implants-global-market-report
Minimally Invasive Glaucoma Surgery Migs Devices Market Report 2026
Ocular Hypertension Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/ocular-hypertension-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
